Ray Taylor

401 total citations
9 papers, 305 citations indexed

About

Ray Taylor is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Ray Taylor has authored 9 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Epidemiology. Recurrent topics in Ray Taylor's work include Viral Infections and Vectors (7 papers), Viral Infections and Outbreaks Research (5 papers) and Mosquito-borne diseases and control (5 papers). Ray Taylor is often cited by papers focused on Viral Infections and Vectors (7 papers), Viral Infections and Outbreaks Research (5 papers) and Mosquito-borne diseases and control (5 papers). Ray Taylor collaborates with scholars based in United States, Australia and Canada. Ray Taylor's co-authors include William Sheridan, Amanda Mathis, Y.S. Babu, Justin G. Julander, Brian B. Gowen, Dennis M. Walling, James F. Demarest, J. T. Evans, John D. Morrey and Arnaud J. Van Wettere and has published in prestigious journals such as Science Translational Medicine, Antiviral Research and Viruses.

In The Last Decade

Ray Taylor

9 papers receiving 295 citations

Peers

Ray Taylor

ID

PHEOH

EPIDE

MB

CTM

Filippo Dragoni Italy

Fábio Luís Lima Monteiro Brazil

Adele Boccuto Italy

Haruaki Nobori Japan

Said Hassounah Canada

Wajihul Hasan Khan India

Sarah S. Killingbeck United States

Olivia Goethals Belgium

Eric J. Sefing United States

Jared Pitts United States

Filippo Dragoni Italy

Ray Taylor

238 ×1.0

ID

81 ×0.6

PHEOH

53 ×0.9

EPIDE

29 ×0.7

MB

17 ×0.7

CTM

Citations per year, relative to Ray Taylor Ray Taylor (= 1×) peers Filippo Dragoni

Countries citing papers authored by Ray Taylor

Since Specialization

Citations

This map shows the geographic impact of Ray Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray Taylor more than expected).

Fields of papers citing papers by Ray Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ray Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray Taylor. The network helps show where Ray Taylor may publish in the future.

Co-authorship network of co-authors of Ray Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Ray Taylor. A scholar is included among the top collaborators of Ray Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ray Taylor. Ray Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Mathis, Amanda, David Collins, Sylvia Dobo, et al.. (2022). Pharmacokinetics and Safety of the Nucleoside Analog Antiviral Drug Galidesivir Administered to Healthy Adult Subjects. Clinical Pharmacology in Drug Development. 11(4). 467–474. 10 indexed citations

2.

Julander, Justin G., James F. Demarest, Ray Taylor, et al.. (2021). An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral. Antiviral Research. 195. 105180–105180. 53 indexed citations

3.

Taylor, Ray, Richard A. Bowen, James F. Demarest, et al.. (2021). Activity of Galidesivir in a Hamster Model of SARS-CoV-2. Viruses. 14(1). 8–8. 14 indexed citations

4.

Lim, So‐Yon, Christa E. Osuna, Katharine Best, et al.. (2020). A direct-acting antiviral drug abrogates viremia in Zika virus–infected rhesus macaques. Science Translational Medicine. 12(547). 20 indexed citations

5.

Westover, Jonna B., Amanda Mathis, Ray Taylor, et al.. (2018). Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters. Antiviral Research. 156. 38–45. 54 indexed citations

6.

Warren, Travis K., et al.. (2017). Efficacy of Galidesivir against Ebola Virus Disease in Rhesus Monkeys. Open Forum Infectious Diseases. 4(suppl_1). S302–S302. 10 indexed citations

7.

Lim, So‐Yon, Christa E. Osuna, Jessica R. Lakritz, et al.. (2017). Galidesivir, a Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged with Zika Virus. Open Forum Infectious Diseases. 4(suppl_1). S55–S55. 12 indexed citations

8.

Julander, Justin G., Venkatraman Siddharthan, J. T. Evans, et al.. (2016). Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model. Antiviral Research. 137. 14–22. 127 indexed citations

9.

Lim, So‐Yon, Christa E. Osuna, Ray Taylor, et al.. (2016). BCX4430, a Broad-Spectrum Adenosine Analog Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged With Zika Virus. Open Forum Infectious Diseases. 3(suppl_1). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact